A clinical trial of dextromethorphan in amyotrophic lateral sclerosis
Introduction - Although the cause of amyotrophic lateral sclerosis (ALS) is unknown, excitotoxicity mediated by glutamate has been implicated. Dextromethorphan is a NMDA-glutamate receptor antagonist with neuroprotective properties. Material and methods - The effect of treatment with dextromethorpha...
Сохранить в:
| Главные авторы: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | английский |
| Опубликовано: |
2009
|
| Online-ссылка: | https://doi.org/10.1111/j.1600-0404.1997.tb00231.x |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|